SavedAdd your journal

Journals / Anestezi Dergisi / 2019 / Cilt: 27 - Sayı: 2

Anesthesia Management in Patient with Chanarin-Dorfman Syndrome

Chanarin Dorfman Sendromlu Hastada Anestezi Yönetimi

Alparslan KOÇ
Nurhan EREN
Pages
151–154
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In rare cases such as CDS, we think that TIVA can be used safely for anesthesia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this case, we present total intravenous anesthesia (TIVA) in a patient with the diagnosis of Chanarin-Dorfman Syndrome (CDS) who will be operated for bladder stone.
📊
Key Findings & Data:Also an INR of 1.71 was detected.
💡
Conclusion & Impact:Conclusion: In rare cases such as CDS, we think that TIVA can be used safely for anesthesia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this case, we present total intravenous anesthesia (TIVA) in a patient with the diagnosis of Chanarin-Dorfman Syndrome (CDS) who will be operated for bladder stone. Method: The patient had a history of esophageal variceal bleeding. Also an INR of 1.71 was detected. General anesthesia was considered when the patient refused regional anesthesia. TIVA was preferred because of isolated hepatotoxic effects of inhaled anesthetic agents. Results: TIVA was performed safely, no intraoperative complication was seen. No significant changes were observed in liver tests performed weekly during the first month. Conclusion: In rare cases such as CDS, we think that TIVA can be used safely for anesthesia.

Özet

Amaç: Biz bu olguda, Chanarin-Dorfman sendromu (CDS) tanısı olan mesane taşı nedeniyle opere edilecek bir hastada total intravenöz anestezi (TİVA) uygulamasını irdeledik. Yöntem: Hastada özofagus varis kanaması öyküsü mevcut idi. Ayrıca tetkiklerinde INR: 1.71 belirlendi. Hastanın rejyonal anesteziyi reddetmesiyle birlikte genel anestezi düşünüldü. İnhaler anestezik ajanların izole hepatotoksik etkileri nedeniyle olguda TİVA tercih edilmiştir. Bulgular: Hastada TİVA güvenle uygulanmış ameliyat sırasında komplikasyon görülmemiştir. Ameliyat sonrası bir aylık süreçte haftalık bakılan karaciğer testlerinde anlamlı değişiklik görülmemiştir. Sonuç: CDS gibi nadir görülen olgularda anestezi amacıyla TİVA uygulamasının güvenle kullanılabileceği düşüncesindeyiz.

🔖

Cite This Article

KOÇ, A., EREN, N. (2019). Anesthesia Management in Patient with Chanarin-Dorfman Syndrome. Anestezi Dergisi, Cilt: 27 - Sayı: 2, 151–154. https://ajindex.com/articles/143604

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Özkale Y, Erol İ, Canan O, Durdu M. Chanarin Dorfman Syndrome: A case report Cukurova Medical Journal 2015;40:614-18. https://doi.org/10.17826/cutf.71286
  2. Bruno C, Bertini E, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome Biochemical and Biophysical Research Communications Elsevier 6 May 2008.
  3. Di Donato S, F. Taroni F. “Disorders of lipid metabolism” in Myology, A. G. Engel and C. Franzini-Armstrong, Eds., 1587-1621,
  4. McGraw Hill, New York, 2004.
  5. Srebrnik A, Brenner S, Ilie B, et al. Dorfman-Chanarin syndrome: morphologic studies and presentation of new cases. Am J Dermapathol. 1998;20:79-85. https://doi.org/10.1097/00000372-199802000-00016
  6. Dorfman ML, Hershko C, Eisenberg S, Sagher F. Ichthyosiform dermatosis with systemic lipidosis. Arch Dermatol. 1974;110:261-6. https://doi.org/10.1001/archderm.1974.01630080059017
  7. Chanarin I, Patel A, Slavin G, Wills EJ, Andrews TM, Stewart G. Neutral lipid storage disease: a new disorder of lipid metabolism. Br Med J. 1975;8:553-5. https://doi.org/10.1136/bmj.1.5957.553
  8. Bolattürk F, Göl Ö, Yetkin M. Chanarin Dorfman Sendromu: Olgu sunumu. Bozok Tıp Dergisi. 2018;10.16919/bozoktip.349928. Gürakan F, Kaymaz F, Koçak N, Örs Ü, Yüce A, Atakan N. A cause of fatty liver: neutral lipid storage disease with ichthyosis-electron microscopic findings. Digest Dis Sci. 1999;44:2214-7. https://doi.org/10.1023/A:1026692301303 Martin JL. Volatile anesthestics and liver injury: a clinical update or what every anesthesiologist should know. Can J Anesth. 2005;52:125-9. https://doi.org/10.1007/BF03027715
  9. Güneş, Y. Yeni inhalasyon ajanları ve hepatotoksisite. Arşiv Kaynak Tarama Dergisi, 2011;20(4):270-7.
  10. Ogawa M, Doi K, Mitsufuji T, Satoh K, Takatori T. Drug induced hepatitis following sevoflurane anesthesia in a child]. Masui. 1991;40:1542-5.
  11. Martin J, Plevak D, Flannery K, et al. Hepatotoxicity after desflurane anesthesia. Anesthesiology 1995;83:1125-9. https://doi.org/10.1097/00000542-199511000-00030
  12. Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: A case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther. 2010;17:219-22. https://doi.org/10.1097/MJT.0b013e318197eacb
  13. Bruun LS, Elkjaer S, Bitsch-Larsen D, Andersen O. Hepatic failure in a child after acetaminophen and sevoflurane exposure. Anesth Analg. 2001;92:1446-8. https://doi.org/10.1097/00000539-200106000-00020
  14. Röhm KD, Suttner SW, Boldt J, Schöllhorn TA, Piper SN. Insignificant effect of desflurane-fent